Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome

Article in Expert Opinion on Investigational Drugs (September 2023)

Production and characterization of mono-PEGylated alpha-1 antitrypsin for augmentation therapy

Article in International Journal of Pharmaceutics (December 2021)

α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?

Article in Anesthesiology (March 2021)